Work

Update in Lung Cancer 2014

Year: 2015

Type: article

Abstract: In the past 2 years, lung cancer research and clinical care have advanced significantly. Advancements in the field have improved outcomes and promise to lead to further reductions in deaths from lung cancer, the leading cause of cancer death worldwide. These advances include identification of new molecular targets for personalized targeted therapy, validation of molecular signatures of lung cancer risk in smokers, progress in lung tumor immunotherapy, and implementation of population-based lung cancer screening with chest computed tomography in the United States. In this review, we highlight recent research in these areas and challenges for the future.

Source: American Journal of Respiratory and Critical Care Medicine

DOI: 10.1164/rccm.201504-0756up

Authors: Avrum Spira, Balazs Halmos, Charles A. Powell

Institutions: Boston University, Columbia University Irving Medical Center, Icahn School of Medicine at Mount Sinai

Language: English

Topic: Lung Cancer Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funder: National Cancer Institute